PatientPop and Kareo Merge to Create All-In-One Provider Platform Gallery PatientPop and Kareo Merge to Create All-In-One Provider Platform All News, Portfolio News PatientPop and Kareo Merge to Create All-In-One Provider Platform PatientPop and Kareo Merge to Create All-In-One Provider Platformartrix2022-03-09T21:46:32-08:00
Minerva Surgical Announces Pricing of Initial Public Offering Gallery Minerva Surgical Announces Pricing of Initial Public Offering All News, Portfolio News Minerva Surgical Announces Pricing of Initial Public Offering Minerva Surgical Announces Pricing of Initial Public Offeringartrix2022-03-09T20:28:46-08:00
Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering Gallery Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering All News, Portfolio News Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering Ventyx Biosciences Announces Pricing of Upsized Initial Public Offeringartrix2022-03-09T20:26:43-08:00
HistoWiz Raises $32M Series A Financing Gallery HistoWiz Raises $32M Series A Financing All News, Portfolio News HistoWiz Raises $32M Series A Financing HistoWiz Raises $32M Series A Financingartrix2022-03-09T20:19:19-08:00
Neurogastrx Secures $60M in Series B Financing Gallery Neurogastrx Secures $60M in Series B Financing All News, Vivo News Neurogastrx Secures $60M in Series B Financing Neurogastrx Secures $60M in Series B Financingartrix2022-03-09T20:17:13-08:00
Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency Gallery Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency All News, Portfolio News Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiencyartrix2022-03-09T20:15:49-08:00
Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK® Gallery Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK® All News, Portfolio News Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK® Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK®artrix2022-03-09T20:14:24-08:00
Sera Prognostics Announces Pricing of Initial Public Offering Gallery Sera Prognostics Announces Pricing of Initial Public Offering All News, Portfolio News Sera Prognostics Announces Pricing of Initial Public Offering Sera Prognostics Announces Pricing of Initial Public Offeringartrix2022-03-09T20:12:23-08:00
Sinovac is Granted Emergency Use by the World Health Organization (WHO) Gallery Sinovac is Granted Emergency Use by the World Health Organization (WHO) All News, Portfolio News Sinovac is Granted Emergency Use by the World Health Organization (WHO) Sinovac is Granted Emergency Use by the World Health Organization (WHO)artrix2022-03-09T20:11:05-08:00
Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment Gallery Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment All News, Portfolio News Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatmentartrix2022-03-09T20:09:37-08:00
